ACETIC ACID, GLACIAL; HYDROCORTISONE - Generic Drug Details

What are the generic sources for acetic acid, glacial; hydrocortisone and what is the scope of patent protection?

Acetic acid, glacial; hydrocortisone is the generic ingredient in six branded drugs marketed by Actavis Mid Atlantic, Kv Pharm, Bausch And Lomb, Cosette, Taro, Wockhardt, Warner Chilcott, Saptalis Pharms, and Bayer Pharms, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.

Three suppliers are listed for this compound.

Summary for ACETIC ACID, GLACIAL; HYDROCORTISONE

US Patents:	0
Tradenames:	6
Applicants:	9
NDAs:	9
Finished Product Suppliers / Packagers:	3
Raw Ingredient (Bulk) Api Vendors:	1
DailyMed Link:	ACETIC ACID, GLACIAL; HYDROCORTISONE at DailyMed

Pharmacology for ACETIC ACID, GLACIAL; HYDROCORTISONE

Drug Class	Corticosteroid
Mechanism of Action	Corticosteroid Hormone Receptor Agonists

Anatomical Therapeutic Chemical (ATC) Classes for ACETIC ACID, GLACIAL; HYDROCORTISONE

A01AC	Corticosteroids for local oral treatment
A01A	STOMATOLOGICAL PREPARATIONS
A01	STOMATOLOGICAL PREPARATIONS
A	Alimentary tract and metabolism

A07EA	Corticosteroids acting locally
A07E	INTESTINAL ANTIINFLAMMATORY AGENTS
A07	ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS
A	Alimentary tract and metabolism

C05AA	Corticosteroids
C05A	AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
C05	VASOPROTECTIVES
C	Cardiovascular system

D07AA	Corticosteroids, weak (group I)
D07A	CORTICOSTEROIDS, PLAIN
D07	CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS
D	Dermatologicals

D07XA	Corticosteroids, weak, other combinations
D07X	CORTICOSTEROIDS, OTHER COMBINATIONS
D07	CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS
D	Dermatologicals

G01AD	Organic acids
G01A	ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS
G01	GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS
G	Genito-urinary system and sex hormones

H02AB	Glucocorticoids
H02A	CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
H02	CORTICOSTEROIDS FOR SYSTEMIC USE
H	Systemic hormonal preparations, excluding sex hormones and insulins

S01BA	Corticosteroids, plain
S01B	ANTIINFLAMMATORY AGENTS
S01	OPHTHALMOLOGICALS
S	Sensory organs

S01CB	Corticosteroids/antiinfectives/mydriatics in combination
S01C	ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION
S01	OPHTHALMOLOGICALS
S	Sensory organs

S02AA	Antiinfectives
S02A	ANTIINFECTIVES
S02	OTOLOGICALS
S	Sensory organs

S02BA	Corticosteroids
S02B	CORTICOSTEROIDS
S02	OTOLOGICALS
S	Sensory organs

US Patents and Regulatory Information for ACETIC ACID, GLACIAL; HYDROCORTISONE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Saptalis Pharms	VOSOL HC	acetic acid, glacial; hydrocortisone	SOLUTION/DROPS;OTIC	012770-001	Approved Prior to Jan 1, 1982	AT	RX	Yes	Yes
Actavis Mid Atlantic	ACETASOL HC	acetic acid, glacial; hydrocortisone	SOLUTION/DROPS;OTIC	087143-001	Jan 13, 1982		DISCN	No	No
Bayer Pharms	NEO-CORT-DOME	acetic acid, glacial; hydrocortisone; neomycin sulfate	SUSPENSION/DROPS;OTIC	050238-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Cosette	HYDROCORTISONE AND ACETIC ACID	acetic acid, glacial; hydrocortisone	SOLUTION/DROPS;OTIC	040609-001	Feb 6, 2006	AT	RX	No	No
Wockhardt	HYDROCORTISONE AND ACETIC ACID	acetic acid, glacial; hydrocortisone	SOLUTION/DROPS;OTIC	040168-001	Aug 30, 1996		DISCN	No	No
Taro	HYDROCORTISONE AND ACETIC ACID	acetic acid, glacial; hydrocortisone	SOLUTION/DROPS;OTIC	088759-001	Mar 4, 1985	AT	RX	Yes	Yes

ACETIC ACID, GLACIAL; HYDROCORTISONE Market Analysis and Financial Projection

Last updated: February 14, 2026

What are the market dynamics for acetic acid, glacial?

Market Overview

Acetic acid, glacial, primarily produced via methanol carbonylation, is used in manufacturing vinyl acetate monomer (VAM), acetic anhydride, and purified acetic acid. The global demand is driven by its application in adhesives, paints, coatings, and textiles.

Key Market Drivers

• VAM Production: VAM accounts for approximately 80% of acetic acid consumption. The expansion of polymer industries in Asia-Pacific supports demand.
• Textile Industry Growth: Acetic acid is used in dyeing and finishing processes, especially in emerging markets.
• Regulatory Environment: Restrictions on the use of certain solvents have heightened demand for acetic acid derivatives as eco-friendly solvents.

Market Challenges

• Raw Material Prices: Fluctuations in methanol prices impact production costs.
• Environmental Regulations: Stricter emissions standards for manufacturing facilities increase compliance costs.
• Alternative Technologies: Development of bio-based acetic acid could shift traditional supply chains.

Market Size & Forecast

• 2022 global market size: approximately USD 9.5 billion.
• Compound annual growth rate (CAGR): 4% (2023–2028), driven by industrial expansion in Asia-Pacific.
• Key players include Celanese Corporation, LD Citrate, and Anhui Wanwei Group.

Regional Insights

Region	Market Share (2022)	Growth Drivers
Asia-Pacific	55%	Industrial expansion, urbanization
North America	20%	Oil & gas, chemicals industry
Europe	15%	Regulated manufacturing standards
Rest of World	10%	Infrastructure development

---

How is the financial trajectory shaped for hydrocortisone?

Market Overview

Hydrocortisone is a corticosteroid used in treating inflammation, allergies, and certain autoimmune conditions. It is produced via synthetic chemical processes, with a significant portion supplied by generic manufacturers.

Market Drivers

• Aging Populations: Increased prevalence of conditions requiring anti-inflammatory therapy.
• Chronic Disease Management: Long-term use in autoimmune disease treatment.
• Generic Market Expansion: Cost pressures push demand for affordable hydrocortisone formulations.

Market Challenges

• Regulatory Hurdles: Stringent quality control for biosimilar and generic products.
• Patent Expirations: Mean market share shifts from brand-name to generic manufacturers.
• Supply Chain Disruptions: Raw material sourcing, especially for steroid intermediates, faces volatility amid geopolitical tensions.

Market Size & Growth

• Estimated 2022 market value: USD 650 million.
• Projected CAGR: 3% (2023–2028).
• Dominant companies: Mylan (now part of Viatris), Sandoz, Hikma Pharmaceuticals.

Geographic Summary

Region	Market Share (2022)	Growth Factors
North America	40%	High healthcare expenditure, aging population
Europe	30%	Healthcare systems favor low-cost generics
Asia-Pacific	20%	Rising healthcare infrastructure
Rest of World	10%	Growing access to medicines in developing economies

---

What are the key factors influencing future market trends?

Acetic Acid, Glacial

• Environmental policies will continue to influence production practices.
• Technological innovations aimed at bio-based production may affect traditional supply chains.
• Emerging markets will sustain demand growth, especially where manufacturing infrastructure is expanding.

Hydrocortisone

• Regulatory approvals for biosimilars may increase competition.
• Healthcare reforms in emerging markets can expand access and drive sales.
• Price sensitivity will favor generic production, maintaining stable profit margins.

What are the investment considerations?

• Acetic acid's potential dependence on raw material prices suggests vulnerability to external shocks.
• Hydrocortisone's market stability is linked to healthcare policy shifts and patent landscapes.
• Both sectors experience moderate growth, with opportunities in geographic expansion and technological innovation.

Key Takeaways

1. The acetic acid market is expected to grow 4% annually until 2028, heavily influenced by industrial demand and regional manufacturing capacity.
2. Hydrocortisone's global market size approaches USD 650 million, with a steady 3% CAGR driven by aging populations and generic drug proliferation.
3. Raw material prices and regulatory landscapes pose notable risks for acetic acid producers.
4. Generic and biosimilar drug markets will shape hydrocortisone's competitive dynamics.
5. Asia-Pacific dominates both markets, emphasizing regional growth and manufacturing hubs.

FAQs

1. Will bio-based acetic acid disrupt traditional production?
Yes, bio-based processes are emerging as alternatives, which could influence cost structures and supply chains, especially if scaling proves economically viable.

2. How do patent expirations affect hydrocortisone?
Patent expirations allow generic manufacturers to enter the market, increasing competition and reducing prices.

3. What sustainability initiatives impact acetic acid manufacturing?
Standards aimed at reducing emissions and waste generation result in higher compliance costs but promote eco-friendly production methods.

4. Are there new therapeutic uses expanding hydrocortisone application?
Research is ongoing into its use for chronic inflammatory conditions, but mainstream applications remain consistent.

5. Which regions offer the highest growth potential for both markets?
Emerging markets in Asia-Pacific show substantial growth prospects, driven by expanding industrial bases and healthcare infrastructure.

---

Sources

1. MarketWatch, "Global Acetic Acid Market Size," 2022.
2. GlobalData, "Hydrocortisone Market Analysis," 2023.
3. ICIS Chemical Business, "Acetic Acid Market Outlook," 2023.
4. IQVIA, "Global Healthcare Data," 2023.
5. industry reports, "Bio-based Chemicals and Pharmaceuticals," 2022.